We provide a comprehensive analysis of national health priorities and financing mechanisms to align market strategies with country needs and investment flows. Our team assesses the inclusion of products in national essential medicines and health technology lists and identifies strategic entry points within donor-and government-funded programs. This ensures our clients position their offerings where they can achieve the greatest impact and sustainability.

  • Health Policy and Strategy Review: Analyze national health policies, strategies, and sector plans to identify alignment opportunities with country priorities.
  • Health Financing Mechanism Analysis: Map public and donor-funded health financing flows, including national budgets, insurance schemes, and vertical programs.
  • Product Inclusion Assessment: Evaluate the status of product registration and inclusion in national essential medicines lists (EMLs) and health technology assessments (HTAs).
  • Stakeholder and Program Mapping: Identify key government institutions, donors, and implementing partners influencing procurement and program design.
  • Market Entry and Positioning Strategy: Recommend strategic entry points and engagement pathways to optimize product adoption, funding eligibility, and long-term sustainability.